These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7049292)

  • 41. Comparative effects of amitriptyline and amineptine in patients affected by anxious depression.
    Rampello L; Nicoletti G; Raffaele R; Drago F
    Neuropsychobiology; 1995; 31(3):130-4. PubMed ID: 7609861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of phenelzine and amitriptyline.
    Adams F
    J Clin Psychiatry; 1982 Nov; 43(11):472. PubMed ID: 7174627
    [No Abstract]   [Full Text] [Related]  

  • 43. [Double-blind comparative study of alprazolam (Xanax) and amitriptyline in the treatment of anxiety associated with depression].
    Bernardi F; Cairoli S; D'Aurizio C; De Rosa A; Grasso A; Sannino V; Savoldi F; Sorge F; Casadei GL
    Minerva Psichiatr; 1988; 29(4):203-10. PubMed ID: 3074234
    [No Abstract]   [Full Text] [Related]  

  • 44. Tianeptine and amitriptyline. Controlled double-blind trial in depressed alcoholic patients.
    Lôo H; Malka R; Defrance R; Barrucand D; Benard JY; Niox-Rivière H; Raab A; Sarda A; Vachonfrance G; Kamoun A
    Neuropsychobiology; 1988; 19(2):79-85. PubMed ID: 3067116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenelzine treatment of melancholia.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
    J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
    Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
    Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atypical depression.
    Davidson JR; Miller RD; Turnbull CD; Sullivan JL
    Arch Gen Psychiatry; 1982 May; 39(5):527-34. PubMed ID: 7092486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 50. A double blind trial of phenelzine and amitriptyline in depressed out-patients.
    Kay DW; Garside RF; Fahy TJ
    Br J Psychiatry; 1974 Feb; 124(579):219. PubMed ID: 4596674
    [No Abstract]   [Full Text] [Related]  

  • 51. Double-blind study of imipramine versus phenelzine in Melancholias and Dysthymic Disorders.
    Vallejo J; Gasto C; Catalan R; Salamero M
    Br J Psychiatry; 1987 Nov; 151():639-42. PubMed ID: 3446308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The treatment of depression in patients with epilepsy. A double-blind trial.
    Robertson MM; Trimble MR
    J Affect Disord; 1985 Sep; 9(2):127-36. PubMed ID: 2932485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoamine oxidase inhibitors. A review of antidepressant effectiveness.
    Quitkin F; Rifkin A; Klein DF
    Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and pharmacokinetic factors affecting response to phenelzine.
    Tyrer P; Gardner M; Lambourn J; Whitford M
    Br J Psychiatry; 1980 Apr; 136():359-65. PubMed ID: 6992903
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline.
    Guelfi JD; Pichot P; Dreyfus JF
    Neuropsychobiology; 1989; 22(1):41-8. PubMed ID: 2700774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A double-blind trial of phenelzine in bulimia.
    Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
    J Psychiatr Res; 1985; 19(2-3):485-9. PubMed ID: 3900362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of adinazolam, amitriptyline, and placebo in the treatment of melancholic depression.
    Hicks F; Robins E; Murphy GE
    Psychiatry Res; 1988 Feb; 23(2):221-7. PubMed ID: 3283804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study of refractory cases of depressive illnesses and their response to combined antidepressant treatment.
    Sethna ER
    Br J Psychiatry; 1974 Mar; 124(0):265-72. PubMed ID: 4599813
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of post-traumatic stress syndrome].
    Lepine JP; Darves-Bornoz JM
    Acta Psychiatr Belg; 1993; 93(3):121-35. PubMed ID: 8030427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.